Persistent MALT Lymphoma With Plasmacytic Differentiation Following Treatment With Rituximab
Am J Dermatopathol
.
2023 May 1;45(5):337-338.
doi: 10.1097/DAD.0000000000002353.
Epub 2022 Dec 7.
Authors
Mohammed Moumen
1
,
Nathan Lewis Bowers
2
,
Robert DeSilverio Jr
3
,
Omar P Sangueza
2
Affiliations
1
School of Medicine, Wake Forest University, Winston-Salem, NC.
2
Departments of Dermatology and Pathology, Wake Forest School of Medicine, Winston Salem, NC; and.
3
Atlantic Dermatopathology, LLC, Essington, PA.
PMID:
36729805
DOI:
10.1097/DAD.0000000000002353
No abstract available
MeSH terms
Humans
Lymphoma, B-Cell, Marginal Zone* / drug therapy
Lymphoma, B-Cell, Marginal Zone* / pathology
Rituximab / therapeutic use
Stomach Neoplasms*
Substances
Rituximab
Supplementary concepts
Familial primary gastric lymphoma